Nokotake
voted
$NVIDIA (NVDA.US)$And the market is currently in a rollercoaster state. Analysts say earnings are strong, but selling pressure continues, and the rise in stock prices seems unsustainable. There is good news and bad news, but it seems that bad news in particular attracts attention and is being sold out of fear or because other investors are selling.
Furthermore, $Super Micro Computer (SMCI.US)$ Earnings were disappointing (again), but would actually raising guidance be a good sign for NVIDIA?
It's strange that the same month's profits are supposed to be great, but the stock is being sold for $800 or $700, and it's a hot topic.
Furthermore, $Super Micro Computer (SMCI.US)$ Earnings were disappointing (again), but would actually raising guidance be a good sign for NVIDIA?
It's strange that the same month's profits are supposed to be great, but the stock is being sold for $800 or $700, and it's a hot topic.
Translated
4
1
Nokotake
liked
$Aquestive Therapeutics (AQST.US)$
One of my favorite bio stocks.
Although negative financial results were expected compared to the same period last year, the settlement was positive. There is no doubt that a great product will come out by the end of 2025, so I think it's really time to buy it.
The reason it has been sold until now is due to excessive expectations and product delays. The essence of product awesomeness remains unchanged.
One of my favorite bio stocks.
Although negative financial results were expected compared to the same period last year, the settlement was positive. There is no doubt that a great product will come out by the end of 2025, so I think it's really time to buy it.
The reason it has been sold until now is due to excessive expectations and product delays. The essence of product awesomeness remains unchanged.
Translated
5
$Jumia Technologies (JMIA.US)$
There has been a major crash after the financial results. It would be premature to grab this place as a fallen knife. I think it will probably fall too much once and then rebound again.
Statistically, it is expected to drop to around $2 to $3.
If you're speaking from a long-term perspective, don't add it here; add it when it falls. If you look at it from a short-term perspective, the correct answer is to run away if you fight back.
There has been a major crash after the financial results. It would be premature to grab this place as a fallen knife. I think it will probably fall too much once and then rebound again.
Statistically, it is expected to drop to around $2 to $3.
If you're speaking from a long-term perspective, don't add it here; add it when it falls. If you look at it from a short-term perspective, the correct answer is to run away if you fight back.
Translated
20
1
$BioXcel Therapeutics (BTAI.US)$
Compared to the same period last year, sales doubled, and the deficit was drastically reduced. The consensus has also been exceeded. The situation is bad, so I don't know how far it will go, but it's something to watch today.
Compared to the same period last year, sales doubled, and the deficit was drastically reduced. The consensus has also been exceeded. The situation is bad, so I don't know how far it will go, but it's something to watch today.
Translated
2
$BioXcel Therapeutics (BTAI.US)$
One of my favorite bio stocks.
Profitability is improving, so it may increase with the current financial results. Wouldn't they go to a pretty good place depending on the closing air on Monday?
One of my favorite bio stocks.
Profitability is improving, so it may increase with the current financial results. Wouldn't they go to a pretty good place depending on the closing air on Monday?
Translated
2